SAB NewsThe Science Advisory Board to Present Study Results at the Mid-Atlantic BIO/MED Conference, Baltimore, MD, Dec 3-4, 2003Posted 11/12/2003 Don’t miss the opportunity to hear The Science Advisory Board’s Director of Scientific and Medical Communications, Tamara Zemlo, Ph.D., MPH present an overview of our last twenty studies at the Mid-Atlantic BIO/MED Conference www.biomedexpo.com. Dr. Zemlo’s presentation will take place on December 4th from 10:00AM to 1:00PM and follows influential keynote speakers that include Mark B. McClellan, M.D., Ph.D. (Commissioner of the FDA), Steven M. Paul, M.D. (President, Lilly Research Laboratories) and William A. Haseltine, Ph.D. (Chairman and CEO, Human Genome Sciences, Inc.). In her talk, Enabling Discovery: The View From the Lab Bench, Dr. Zemlo and colleagues will showcase the experiences and opinions of thousands of members of The Science Advisory Board on the instrumentation and consumables that enable cutting-edge research in pharmaceutical, biotechnology and government labs. Her presentation will allow Prinicipal Investigators, Chief Scientific Officers, R&D Directors, Laboratory Managers and other attendees to benchmark their own R&D against the technology preferences of researchers in the areas of cell biology, drug discovery, genetics, microbiology, molecular biology, pharmacogenomics and proteomics. Conference organizer E.J. Krause & Associates has generously extended a 25% discount to all members of The Science Advisory Board who wish to attend the conference because of the vital role they play in creating the tools and technologies that drive life science research. To receive your special member discount, contact Addy Kennedy at E.J. Krause & Associates before December 1st. Be sure to mention that you are a member of The Science Advisory Board. Ms. Kennedy can be reached by calling 301.493.5500 or sending an email to kennedy@ejkrause.com BIO/MED is the premier conference and exhibition targeting the bottlenecks, the barriers and the business opportunities in the Mid-Atlantic biomedical technology industry. The Mid-Atlantic region represents the United States' strongest concentration of biomedical science research and discovery, pharmaceutical R&D, clinical centers of excellence, and federal legislative and regulatory policy centers. With an anticipated attendance of more than 2,000 individuals, this conference offers members an excellent opportunity to network with other researchers in the discovery process, bio and pharma executives in the development process, clinical and medical specialists in the proving process, and other key stakeholders including investors, venture capitalists and service providers. “The Science Advisory Board is proud to be a supporting partner of the Mid-Atlantic BIO/MED Conference,” says Zemlo, “Our presentation and the presence of our members will help to elevate the visibility of The Science Advisory Board as the premier biomedical organization for shaping the future tools and technologies that will support tomorrow’s scientific and medical endeavors.” |
|
